Europlasma S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 7.24 million compared to EUR 3.02 million a year ago. Net loss was EUR 2.44 million compared to EUR 11.13 million a year ago.

Basic loss per share from continuing operations was EUR 120.